摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-dihydroquinazolino[4,3-b]quinazolin-8-one | 109477-69-2

中文名称
——
中文别名
——
英文名称
5,6-dihydroquinazolino[4,3-b]quinazolin-8-one
英文别名
5,6-dihydro-8H-quinazolino[4,3-b]quinazolin-8-one;7-Oxo-5.6-dihydro-7H-5.6a.12-triaza-benzanthracen;8H-Quinazolino[4,3-b]quinazolin-8-one, 5,6-dihydro-
5,6-dihydroquinazolino[4,3-b]quinazolin-8-one化学式
CAS
109477-69-2
化学式
C15H11N3O
mdl
——
分子量
249.272
InChiKey
IWXYHQNHTVFXOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    185-186 °C(Solv: ethanol (64-17-5))
  • 沸点:
    471.2±48.0 °C(Predicted)
  • 密度:
    1.40±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    44.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    骆驼宁碱A衍生物及其制备和在防治植物病毒病菌病中的应用
    摘要:
    本发明涉及骆驼宁碱A衍生物I‑1~I‑12及其制备方法和在防治植物病毒病菌病中的应用。本发明的色胺酮类衍生物I‑1~I‑12显示出抗植物病毒活性,能很好地抑制烟草花叶病毒,同时该类化合物也表现出广谱的抗植物病菌活性,且对苹果轮纹病菌的抑制活性突出。
    公开号:
    CN113999231A
点击查看最新优质反应信息

文献信息

  • Auto-Redox Reaction:  Tin(II) Chloride-Mediated One-Step Reductive Cyclization Leading to the Synthesis of Novel Biheterocyclic 5,6-Dihydro-quinazolino[4,3-<i>b</i>]quinazolin-8-ones with Three-Point Diversity
    作者:Abhijeet Deb Roy、Arunachalam Subramanian、Raja Roy
    DOI:10.1021/jo0518912
    日期:2006.1.1
    A tin(II) chloride-mediated short, efficient, and practical regioselective synthesis of biheterocyclic 5,6-dihydro-quinazolino[4,3-b]quinazolin-8-ones with three-point diversity is reported. A one-step reductive transformation of 2-(2-nitrophenyl)-3H-quinazolin-4-one in various alcohols furnished the desired tetracyclic product in good yields with high purity.
  • Luotonin A and Its Derivatives as Novel Antiviral and Antiphytopathogenic Fungus Agents
    作者:Yanan Hao、Kaihua Wang、Ziwen Wang、Yuxiu Liu、Dejun Ma、Qingmin Wang
    DOI:10.1021/acs.jafc.0c04278
    日期:2020.8.19
    Plant diseases caused by viruses and fungi have posed a serious threat to global agricultural production. The discovery of new leads based on natural products is an important way to innovate pesticides. In this work, natural product luotonin A was found to have good antiviral activity against tobacco mosaic virus (TMV) for the first time. A series of luotonin A derivatives were designed, synthesized, and evaluated for their antiviral activities and fungicidal activities systematically. Most compounds displayed better antiviral activities against TMV than commercial ribavirin. Compounds 9k, 12b, and 12d displayed about similar inhibitory effects as ningnanmycin (inhibitory rates of 55, 57, and 59% at 500 mu g/mL for inactivation, curative, and protection activities in vivo, respectively), the best antiviral agent at present, and emerged as novel antiviral leads for further research. We selected 9k for further antiviral mechanism research via transmission electron microscopy and molecular docking, which revealed that compound 9k can interact with TMV coat protein through the hydrogen bond, leading to its polymerization, thus preventing virus assembly. Further fungicidal activity tests showed that these compounds also showed broad-spectrum fungicidal activities against 14 kinds of phytopathogenic fungi. Especially, compound 14 with a 100% antifungal effect against Botrytis cinereal emerged as a lead for further research. This work provides a reference for the development of agricultural active ingredients based on Chinese medicine plants.
查看更多

同类化合物

阿斯普尼辛B 阿斯普尼辛 D 阿斯普尼辛 苯佐莫文 新骏河毒素 乙酰胺,N-(4-硝基-2-吡啶基)-,氧化(9CI) TAK960抑制剂 PLK1抑制剂(RO3280) 8H-嘧啶并[4,5-b][1,4]二氮杂卓 8-甲基-5,9-二氢-6H-嘧啶并[4,5-b][1,4]重氮基庚英-6-酮 6H-嘧啶并[4,5-b][1,4]二氮杂卓 4-甲基-6,11-二氢-3H-嘧啶并[4,5-b][1,5]苯并二氮杂卓-2,5-二酮 2-氯-7,7-二氟-5-甲基-5,7,8,9-四氢-6H-嘧啶基[4,5-B][1,4]二氮杂-6-酮 2-氯-5-甲基-5,7,8,9-四氢-6H-嘧啶[4,5-B][1,4]二氮杂6-酮 1H-嘧啶并[4,5-b][1,4]二氮杂卓 5-(2-piperidin-1-yl-ethyl)-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one 4-oxo-2-pyridin-4-yl-5,6,8,9-tetrahydro-4H-1,4a,7-triaza-benzocycloheptene-7-carboxylic acid ethyl ester 7-chloro-5-phenyl-1-propyl-1,3-dihydro-pyrido[3,2-e][1,4]diazepin-2-one 6-methoxy-8-methyl-4-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)pteridin-7(8H)-one 4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-N-((1S,2R)-2-hydroxycyclohexyl)-3-methoxybenzamide 8-chloro-1,2,3,4-tetrahydro-pyrazino[2,1-b]quinazolin-6-one hydrochloride salt of 3-(2-chlorophenyl)-7-[(1-hydroxymethylcyclohexyl)amino]-1-methyl-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1 H)-one {2-[4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido-[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoylamino]-ethyl}-carbamic acid tert-butyl ester (7R)-8-cyclohexyl-2-[(4-fluoro-1H-indazol-5-yl)amino]-5-(3-fluorophenyl)-7-methyl-7,8-dihydropteridin-6(5H)-one 7-ethoxy-8-ethyl-9-methyl-1(3),7-dihydro-[1,3]diazepino[2,1-i]purin-10-one 3-(((1H-indol-3-yl)methylene)amino)-3,4-dihydroquinazolin-2(1H)-one 3-[[(7R)-7-benzyl-2,5,8,11,14-pentazatricyclo[8.4.0.02,6]tetradeca-1(14),3,5,10,12-pentaen-8-yl]sulfonyl]benzoic acid 5-(hydroxyamino)-11H-pyrimido[4,5-b][1,5]benzodiazepine 3-ethyl-7-(3-piperidin-1-yl-propyl)-7,12-dihydro-3H-benzo[b]pyrazolo[4',3':5,6]pyrido[4,3-e][1,4]diazepin-6-one (7R)-7-benzyl-8-[2-(trifluoromethoxy)phenyl]sulfonyl-2,5,8,12,14-pentazatricyclo[8.4.0.02,6]tetradeca-1(14),3,5,10,12-pentaene 3-(9-ethylamino-6-oxo-2,3,3a,4-tetrahydro-1H,6H-5,8,10,10b-tetraazabenzo[e]azulen-5-yl)benzoic acid-N'-acetyl hydrazide 7-chloro-2-oxo-5-phenyl-2,3-dihydro-pyrido[3,2-e][1,4]diazepine-1-carboxylic acid allylamide 6-(4-bromobenzylidene)-6,11-dihydro-13H-isoquinolino[3,2-b]quinazolin-13-one (+/-)-9-methylamino-4-oxo-2-pyridin-4-yl-5,6,8,9-tetrahydro-4H-1,4a,7-triaza-benzocycloheptene-7-carboxylic acid ethyl ester 5-benzyl-2-(1H-indol-4-yl)-6a,7,9,10-tetrahydro-[1,4]oxazino[3,4-h]pteridin-6(5H)-one 4-{[7-(cyclopropylmethoxy)-5-methyl-6-oxo-8-(3-thienyl)-5,6-dihydropyrido[3,2-d]pyrimidin-2-yl]amino}-3-methyl-N-(1-methylpiperidin-4-yl)benzamide 6-(4-chlorobenzylidene)-6,11-dihydro-13H-isoquinolino[3,2-b]quinazolin-13-one 6-benzylidene-6,11-dihydro-13H-isoquinolino[3,2-b]quinazolin-13-one 6-(4-methoxybenzylidene)-6,11-dihydro-13H-isoquinolino[3,2-b]quinazolin-13-one 6-{[(4-dimethylamino)phenyl]methylidene}-6,11-dihydro-13H-isoquino[3,2-b]quinazolin-13-one 1H-spiro[pyrimido[4,5-b]quinoline-5,5'-pyrrolo[2,3-d]pyrimidine]-2,2',4,4',6'(1'H,3H,3'H,7'H,10H)-pentaone tert-butyl 3-(4-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxybenzamido) azetidine-1-carboxylate 4-deoxy-4-amino-7,10-methano-5-deazapteroic acid (S)-N,N-dimethyl 2-[3-(9-ethylamino-6-oxo-2,3,3a,4-tetrahydro-1H,6H-5,8,10,10b-tetraazabenzo[e]azulen-5-yl)phenyl]-1,3-oxazole-4-carboxamide diethyl (4-{[4-{[7-(hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methyl-3-oxo-2,3-dihydro-1H-isoindol-4-yl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}benzyl)phosphonate 3-[2-(3-methyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-quinazolin-4-yl]-4-(6H-thieno[2,3-b]pyrrol-4-yl)-pyrrole-2,5-dione 4-((R)-9-cyclopentyl-7-fluoro-5-methyl-6-oxo-7-vinyl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-((R)-piperidin-3-yl)benzamide (S)-N,N-dimethyl 5-[3-(9-methylamino-6-oxo-2,3,3a,4-tetrahydro-1H,6H-5,8,10,10b-tetraazabenzo[e]azulenyl)phenyl]-1,3,4-oxadiazole-2-carboxamide 4-[(6-cyclopentyl-2,5-dimethyl-3-oxo-2,6,8,10-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-9-yl)amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide